22 May 2013
Keywords: phase, iii, results, biogen, interferon, beta, product
Article | 17 October 1994
Product development in the area of multiple sclerosis continues apace
with pivotal trial results becoming available for a number of ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
17 October 1994
21 May 2013
© 2013 thepharmaletter.com